BIOE (Bio Essence) Equity-to-Asset : -10.57 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bio Essence Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bio Essence's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $-2.97 Mil. Bio Essence's Total Assets for the quarter that ended in Dec. 2024 was $0.28 Mil. Therefore, Bio Essence's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was -10.57.

The historical rank and industry rank for Bio Essence's Equity-to-Asset or its related term are showing as below:

BIOE' s Equity-to-Asset Range Over the Past 10 Years
Min: -10.57 Med: -1.2 Max: -0.47
Current: -10.57

During the past 6 years, the highest Equity to Asset Ratio of Bio Essence was -0.47. The lowest was -10.57. And the median was -1.20.

BIOE's Equity-to-Asset is ranked worse than
98.44% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs BIOE: -10.57

Bio Essence Equity-to-Asset Historical Data

The historical data trend for Bio Essence's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Essence Equity-to-Asset Chart

Bio Essence Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Equity-to-Asset

Get a 7-Day Free Trial

-0.97

-1.43

-2.09

-0.60

-10.57

Bio Essence Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Equity-to-Asset	Get a 7-Day Free Trial															-0.60	-2.04	-0.83	-4.11	-10.57

Competitive Comparison of Bio Essence's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bio Essence's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Essence's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bio Essence's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bio Essence's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Bio Essence Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bio Essence's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	-2.969	/	0.281
	=	-10.57

Bio Essence's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	-2.969	/	0.281
	=	-10.57

Bio Essence (OTCPK:BIOE) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Bio Essence Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bio Essence's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio Essence Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bio Essence Corp (OTCPK:BIOE) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

2955 Main Street, Suite 300, Irvine, CA, USA, 92618

Website

https://www.bioessencecorp.com

Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The company is focused on producing health products along with providing original equipment manufacturing and private label services to other companies. The company develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. The company also offers special formulated dietary supplements and medical food.